Medical Director - Heart Failure - US Central / West
About Us
We are a global, family-owned company driven by a passion for innovation. Building on our foundational expertise in carbohydrate chemistry and cell cycle biology, we develop innovative treatments for unmet patient needs, with a focus on iron metabolism and blood-related disorders. With 700+ employees across the USA, the UK, Ireland, the Nordics, and Germany, we are committed to scientific excellence, patient care, and collaborative partnerships with the medical community.
Our Core Values
People‑Driven – We are a family‑held company built on passionate, knowledgeable people. We value integrity, open‑mindedness and respect and are guided by these values in all our endeavors. We respect each individual who becomes a part of our journey, from our employees and partners to our end‑users. And we recognize that the strength in all our collaborations is trust.
Committed to Quality – Quality is our source of inspiration. Quality drives our results. It represents our aspiration for excellence and our focus on driving continual improvements. For our partners and end‑users, quality must always be tangible in our products, processes and people. This way, quality is the promise we keep every day.
Innovating for Better Lives – Innovation is essential in our quest to improve the lives of humans. We seek to address unmet needs through our expertise in iron and carbohydrate‑based pharmaceuticals. We believe in a holistic and collaborative approach to research and innovation, so we work together with the scientific and medical communities to set new standards. We have continued our growth trajectory since we launched our first product in the US, Monoferric® (ferric derisomaltose), through acquisitions, partnerships, and pipeline. Our R&D investments continue to leverage our core competencies, alongside our recent advancements in oncology supportive care. Join us in shaping the future of patient care through innovation and collaboration.
Job Purpose
This role offers the opportunity to help shape Pharmacosmos’ future presence in heart failure while supporting one of the company’s most important clinical development programs. The role sits at the interface of Clinical Development and Medical Affairs and has two complementary objectives: support successful execution and patient recruitment of the ICONIC‑HF trial in the United States through investigator engagement, site support, insight generation, and identification of barriers to study execution; and build the scientific, stakeholder, and market foundation for future IV iron adoption in heart failure, including KOL engagement, strategic insight generation, advocacy development, launch readiness, and future medical‑marketing support. The relative emphasis of the role is expected to evolve over time. During active execution of ICONIC‑HF, the primary focus will be investigator engagement, site support, and insight generation related to trial execution. As the program matures, the center of gravity is expected to shift progressively toward heart failure market understanding, advocacy development, launch readiness, and broader medical affairs support for the future heart failure franchise. The successful candidate will work closely with both the US affiliate and global headquarters in Denmark and will have regular interaction with cross‑functional leadership teams across Clinical Development, Medical Affairs, Strategy and Operations, and Market Access. The role is intended for an individual who enjoys combining scientific engagement, strategic thinking, and execution in a highly collaborative global environment.
Job Responsibilities
Trial Support: ICONIC‑HF Site Engagement and Enablement
The purpose of this pillar is to strengthen investigator engagement, facilitate communication, and generate insights that support successful trial execution. Establish and maintain strong scientific relationships with investigators, study coordinators, and other site personnel involved in ICONIC‑HF. Conduct regular site engagements, virtually and in person where relevant, to understand local opportunities, challenges, operational barriers and operate within compliance, GCP, and trial governance frameworks. Serve as a US‑based scientific liaison between participating sites and the HQ R&